Dr. Duncan M. Geddes

Dr. Duncan M. Geddes's AcademicInfluence.com Rankings

Philosophy

#7176

World Rank

#10349

Historical Rank

Logic

#4246

World Rank

#5516

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Dr. Duncan M. Geddes's Degrees

PhD Respiratory Physiology University of California, San Francisco
Doctorate Internal Medicine University of California, San Francisco

Why Is Dr. Duncan M. Geddes Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Dr. Duncan M. Geddes's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Two-, six-, and 12-minute walking tests in respiratory disease. (1982) (1553)
Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis (1995) (677)
Effect of lung-volume-reduction surgery in patients with severe emphysema. (2000) (405)
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial (2015) (353)
Bronchoscopic volume reduction with valve implants in patients with severe emphysema. (2003) (317)
Progressive airway obliteration in adults and its association with rheumatoid disease. (1977) (313)
Cystic fibrosis in the mouse by targeted insertional mutagenesis (1992) (288)
Incidence, population, and survival of cystic fibrosis in the UK, 1968–95 (1997) (256)
The natural history of lung cancer: a review based on rates of tumour growth. (1979) (252)
Bronchoscopic lung volume reduction for end-stage emphysema: report on the first 98 patients. (2006) (250)
Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. (2005) (250)
Efficient gene transfer to airway epithelium using recombinant Sendai virus (2000) (249)
OXYGEN RELIEVES BREATHLESSNESS IN "PINK PUFFERS" (1981) (227)
Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis (2000) (216)
Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. (1981) (214)
Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis (1993) (192)
Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis. (2007) (171)
Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis (2002) (168)
Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers. (1981) (155)
Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. (2003) (151)
Clinical importance of cystic fibrosis-related diabetes. (2004) (149)
Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium. (1994) (147)
The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium (1999) (139)
Atelectasis and survival after bronchoscopic lung volume reduction for COPD (2010) (137)
Supplemental oxygen and exercise ability in chronic obstructive airways disease. (1988) (136)
Respect (2002) (135)
Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma (1990) (133)
Inhaled corticosteroids: benefits and risks. (1992) (129)
Improving rate of decline of FEV1 in young adults with cystic fibrosis (2005) (128)
Nasal potential difference: a clinical diagnostic test for cystic fibrosis. (1990) (128)
No added benefit from nebulized amiloride in patients with cystic fibrosis. (1993) (126)
Effect of inhaled furosemide on metabisulfite- and methacholine-induced bronchoconstriction and nasal potential difference in asthmatic subjects. (1990) (119)
THEOPHYLLINE PRESCRIBING, SERUM CONCENTRATIONS, AND TOXICITY (1983) (117)
Airways obstruction in rheumatoid arthritis. (1979) (112)
Dihydrocodeine for breathlessness in "pink puffers". (1983) (111)
Gene Therapy Progress and Prospects: Cystic fibrosis (2002) (110)
Height and weight in cystic fibrosis: a cross sectional study (1997) (98)
Chronic airflow obstruction. (1984) (97)
The response of cerebral metastases in small cell lung cancer to systemic chemotherapy. (1990) (95)
Pseudo-steroid resistant asthma. (1999) (92)
α1-ANTITRYPSIN PHENOTYPES IN FIBROSING ALVEOLITIS AND RHEUMATOID ARTHRITIS (1977) (92)
Upper respiratory tract viral infection and mucociliary clearance. (1987) (91)
Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo (2006) (90)
Erythromycin and diffuse panbronchiolitis. (1997) (88)
Nasal epithelial ion transport and genetic analysis of infertile men with congenital bilateral absence of the vas deferens. (1993) (87)
Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatment. (1995) (86)
Cyclosporin as an oral corticosteroid sparing agent in stable asthma. (2000) (83)
Thoracoscopy: assessment of a physician service and comparison of a flexible bronchoscope used as a thoracoscope with a rigid thoracoscope. (1988) (81)
Cystic fibrosis in the United Kingdom, 1968-1988: incidence, population and survival. (1993) (80)
Mannose-binding lectin is present in the infected airway: a possible pulmonary defence mechanism (2008) (69)
Use of ultrasound to enhance nonviral lung gene transfer in vivo (2007) (68)
Two years experience with recombinant human DNase I in the treatment of pulmonary disease in cystic fibrosis. (1995) (67)
Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence. (2001) (64)
Recurrence of recipient Langerhans’ cell histiocytosis following bilateral lung transplantation (1998) (61)
Effect of amiloride and saline on nasal mucociliary clearance and potential difference in cystic fibrosis and normal subjects. (1993) (61)
Reduction of persistent air leak with endoscopic valve implants (2007) (60)
Sendai virus-mediated CFTR gene transfer to the airway epithelium (2007) (59)
SELF-ADMINISTERED HOME INTRAVENOUS ANTIBIOTIC THERAPY IN BRONCHIECTASIS AND ADULT CYSTIC FIBROSIS (1984) (58)
Measurement of nasal potential difference in adult cystic fibrosis, Young's syndrome, and bronchiectasis. (1987) (58)
A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo (2004) (57)
Poly (D, L-lactide-co-glycolide)/DNA microspheres to facilitate prolonged transgene expression in airway epithelium in vitro, ex vivo and in vivo (2003) (57)
The in vivo effects of milrinone on the airways of cystic fibrosis mice and human subjects. (1999) (56)
Keratinocyte growth factor therapy in murine oleic acid-induced acute lung injury. (2005) (56)
Gene Therapy Progress and Prospects: Bringing gene therapy into medical practice: the evolution of international ethics and the regulatory environment (2004) (51)
Pulmonary fibrosis associated with hypersensitivity to gold salts. (1976) (51)
Radiation‐induced lung fibrosis after treatment of small cell carcinoma of the lung with very high‐dose cyclophosphamide (1985) (49)
First pass uptake of 14C-propranolol by the lung. (1979) (49)
The efficacy of a 'master switch gene' HIF-1alpha in a porcine model of chronic myocardial ischaemia. (2005) (48)
Gene therapy for cystic fibrosis: a clinical perspective. (1995) (48)
Role of CT in the management of pneumothorax in patients with complex cystic lung disease. (1997) (47)
Increase in mucociliary clearance in normal man induced by oral high frequency oscillation. (1985) (47)
Pseudomonal infection in cystic fibrosis: the battle continues (2003) (47)
Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I. (1995) (47)
Critical appraisal of the mouse model of myocardial infarction (2004) (46)
Cystic fibrosis and pregnancy. (1992) (46)
Reduction in the adherence of Pseudomonas aeruginosa to native cystic fibrosis epithelium with anti-asialoGM1 antibody and neuraminidase inhibition. (1999) (45)
Asthma prophylaxis agents alter the function of an airway epithelial chloride channel. (1996) (44)
BOOP and COP. (1991) (44)
Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis. (2006) (43)
Experience of totally implantable venous access devices (TIV ADs) in adults with cystic fibrosis over a 13-year period. (2000) (42)
A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. (1991) (42)
Allergie Bronchopulmonary Aspergillosis: A Review (1992) (42)
Gold as an oral corticosteroid sparing agent in stable asthma. (2000) (41)
Effects of purified Pseudomonas rhamnolipids on bioelectric properties of sheep tracheal epithelium. (1993) (41)
Depression of central respiratory drive by nitrazepam. (1978) (39)
Pulmonary deposition of nebulised amiloride in cystic fibrosis: comparison of two nebulisers. (1991) (38)
Reproducibility of dynamically represented acoustic lung images from healthy individuals (2007) (38)
Normal nasal mucociliary clearance in CF children: evidence against a CFTR‐related defect (2004) (37)
The nasal epithelium as a factory for systemic protein delivery. (2002) (37)
Bone marrow stem cells do not repopulate the healthy upper respiratory tract (2002) (37)
Advances in cystic fibrosis gene therapy (2004) (36)
Identification and Functional Characterization of Cytoplasmic Determinants of Plasmid DNA Nuclear Import* (2009) (36)
Potential difference measurements in the lower airway of children with and without cystic fibrosis. (2005) (35)
An evaluation of two aerosol delivery systems for rhDNase. (1997) (34)
Pulmonary disease severity in men with ΔF508 cystic fibrosis and residual chloride secretion (1999) (34)
Newly diagnosed cystic fibrosis in middle and later life. (1985) (33)
Localization and up‐regulation of Mucin (MUC2) gene expression in human nasal biopsies of patients with cystic fibrosis (1997) (32)
Height and weight in cystic fibrosis: a cross sectional study. UK Cystic Fibrosis Survey Management Committee. (1997) (32)
Of isolates and isolation: Pseudomonas aeruginosa in adults with cystic fibrosis (2001) (31)
Collateral ventilation (2006) (31)
Bioelectric characteristics of exon 10 insertional cystic fibrosis mouse: comparison with humans. (1995) (30)
Computed tomography and cystic fibrosis: promises and problems (2007) (30)
Distal intestinal obstruction syndrome in cystic fibrosis treated by oral intestinal lavage, and a case of recurrent obstruction despite normal pancreatic function. (1987) (30)
Exploring the mechanisms of macrolides in cystic fibrosis. (2006) (29)
Effect of nitrazepam and flurazepam on the ventilatory response to carbon dioxide. (1976) (29)
Evaluation of patients undergoing lung volume reduction surgery: ancillary information available from computed tomography. (2000) (28)
Prospects for gene therapy in cystic fibrosis. (1998) (27)
Effect of tolerance induction to immunodominant T-cell epitopes of Sendai virus on gene expression following repeat administration to lung (2006) (26)
Survival estimates for adults with cystic fibrosis born in the United Kingdom between 1947 and 1967 (1999) (26)
Home treatment of patients with cystic fibrosis using the 'Intermate': the first year's experience. (2006) (26)
Update on gene therapy for cystic fibrosis. (2003) (25)
Troleandomycin as an oral corticosteroid sparing agent in stable asthma (2000) (25)
Bactofection of lung epithelial cells in vitro and in vivo using a genetically modified Escherichia coli (2008) (25)
Transepithelial potential difference in cystic fibrosis. (1985) (24)
Evaluation of the porcine ameroid constrictor model of myocardial ischemia for therapeutic angiogenesis studies. (2006) (23)
A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator ( CFTR) gene therapy in patients with cystic fibrosis (2016) (23)
IMPROVING THE EFFICIENCY OF DRUG ADMINISTRATION WITH JET NEBULISERS (1988) (23)
Bronchial casts associated with hilar lymphatic and pulmonary lymphoid abnormalities. (1989) (23)
Pulmonary arterial aneurysms in association with a right ventricular myxoma. (1976) (23)
SCALP COOLING BY THERMOCIRCULATOR (1982) (22)
Effect of heart-lung transplantation on airway potential difference in patients with and without cystic fibrosis. (1991) (21)
Effect and duration of lung volume reduction surgery: mid-term results of the Brompton trial. (2006) (21)
Antimicrobial therapy against Staphylococcus aureus, Pseudomonas aeruginosa, and Pseudomonas cepacia. (1988) (21)
Case reports of death during pregnancy in patients with cystic fibrosis--three out of four patients were colonized with Burkholderia cepacia. (2000) (20)
Small Chronic Pneumothoraces and Pulmonary Parenchymal Abnormalities After Bone Marrow Transplantation (2007) (20)
Propranolol uptake by dog lung: effect of pulmonary artery occlusion and shock lung. (1982) (20)
Prospects for gene therapy in cystic fibrosis (1999) (19)
Characterization and comparison of ion transport across sheep and human airway epithelium. (1994) (19)
Impaired lung uptake of propranolol in human pulmonary emphysema. (1982) (19)
Fatal haemorrhage from mesenchymal cystic hamartoma of the lung. (1995) (19)
Ion transport characteristics of the murine trachea and caecum. (1992) (19)
Are "pink puffers" more breathless than "blue bloaters"? (1983) (19)
Effect of beta-adrenergic blockade on hyperventilation and exercise tolerance in emphysema. (1983) (18)
Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancer (2004) (18)
Obliterative bronchiolitis, cryptogenic organising pneumonitis and bronchiolitis obliterans organizing pneumonia: three names for two different conditions. (1991) (18)
Malabsorption of vitamin E in cystic fibrosis improved after ursodeoxycholic acid (1995) (18)
In vivo imaging of gene transfer to the respiratory tract. (2008) (18)
Heat shock proteins in cancer therapy. (2000) (18)
Management of influenza in patients with asthma or chronic obstructive pulmonary disease. (2001) (17)
The selectivity of the beta-adrenoceptor for ventilation in man. (1982) (17)
Effect of IBMX and alkaline phosphatase inhibitors on Cl- secretion in G551D cystic fibrosis mutant mice. (1998) (17)
Bringing new treatments to the bedside in cystic fibrosis (2004) (17)
Cystic fibrosis: future trends in care. (1988) (17)
Evidence against transmission of Pseudomonas aeruginosa by hands and stethoscopes in a cystic fibrosis unit. (2002) (17)
Inhaled corticosteroids: benefits and risks. (1996) (17)
Endobronchial volume reduction: a myth or a marvel? (2004) (16)
Methodological Aspects of Bronchoscopic Lung Volume Reduction with a Proprietary System (2003) (16)
alpha 1-antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis. (1977) (16)
Quality of life in lung cancer. (1991) (16)
ABSENCE OF ELECTROCHEMICAL DEFECT OF CYSTIC FIBROSIS IN TRANSPLANTED LUNG (1987) (15)
Partial resolution of acute interstitial pneumonia in native lung after single lung transplantation. (1996) (15)
Ventilatory saving by external chest wall compression or oral high-frequency oscillation in normal subjects and those with chronic airflow obstruction. (1985) (15)
Bioelectric properties of cystic fibrosis airways obtained at heart-lung transplantation. (1992) (15)
Troleandomycin as an oral corticosteroid steroid sparing agent in stable asthma. (2001) (14)
Osteoporosis and cystic fibrosis. (1993) (14)
Prospects for gene therapy in lung disease. (2001) (14)
Moratorium on Kveim test (1993) (14)
Comparison of reports on lung function tests made by chest physicians with those made by a simple computer program. (1978) (14)
An oxygen conserving nasal cannula. (1985) (13)
Three-dimensional computed tomography bronchoscopy using clinical datasets: a comparison with fibreoptic bronchoscopy. (1997) (13)
A mixed message for cystic fibrosis gene therapy (1994) (13)
High-dose cyclophosphamide with autologous marrow transplantation for small cell carcinoma of the bronchus (2004) (12)
The effect of varying tonicity on nasal epithelial ion transport in cystic fibrosis. (2005) (12)
Low-frequency ultrasound increases non-viral gene transfer to the mouse lung. (2010) (12)
Biomarkers for cystic fibrosis: are we progressing? (2007) (12)
The CF gene: 10 years on (1999) (12)
Recall lung pneumonitis due to carmustine after radiotherapy. (1995) (12)
High-dose cyclophosphamide with autologous marrow transplantation as initial treatment of small cell carcinoma of the bronchus (2004) (12)
Effects of altering dosing on cationic liposome-mediated gene transfer to the respiratory epithelium (1999) (12)
Treating patients with asthma who are dependent on systemic steroids. (1989) (12)
Cystic fibrosis. (2002) (11)
Inflammation in cystic fibrosis--when and why? Friend or foe? (2007) (11)
Trimethoprim and tetracycline inhibit airway epithelial sodium absorption. (1996) (11)
Methotrexate in asthma (1991) (11)
Where we are now with rhDNase (1999) (11)
Breathlessness and exercise tolerance in chronic airflow obstruction: 2-hourly versus 4-hourly salbutamol by inhalation. (1983) (11)
UK cystic fibrosis gene therapy consortium tracking study: Exhaled breath condensate pH increases with treatment of an infective exacerbation (2007) (10)
DIAGNOSIS AND MANAGEMENT OF CYSTIC FIBROSIS (1982) (10)
Gene therapy for cystic fibrosis (1997) (10)
Endogenous opioids (endorphins) and the control of breathing. (1981) (10)
Gene therapy for cystic fibrosis (2001) (10)
Sarcoidosis in two patients with cystic fibrosis: a fortuitous association? (1987) (10)
Vascular oligonucleotide transfer facilitated by a polymer-coated stent. (2005) (10)
New treatments for cystic fibrosis. (1992) (10)
Brave new world for interventional bronchoscopy (2005) (10)
Airway surface liquid calcium modulates chloride permeability in the cystic fibrosis airway. (2003) (10)
INSPIRATION-PHASED OXYGEN DELIVERY (1984) (10)
Pulmonary Gene Therapy (2003) (9)
Aerosol deposition in the human lung: effect of high-frequency oscillation on the deposition characteristics of an inhaled nebulized aerosol. (1988) (9)
In vivo transfer of bacterial marker genes results in differing levels of gene expression and tumor progression in immunocompetent and immunodeficient mice. (1999) (9)
First-pass lung uptake of propranolol enhanced in anaesthetized dogs. (1981) (9)
Sequential chemotherapy in good-prognosis patients with small-cell lung cancer (2004) (9)
The role of heart and lung transplantation in the treatment of cystic fibrosis. (1989) (9)
COMPUTERIZED AXIAL TOMOGRAPHY IN THE PRETREATMENT ASSESSMENT OF SMALL-CELL CARCINOMA OF THE BRONCHUS (1981) (9)
Carbimazole and exercise tolerance in chronic airflow obstruction. (1982) (8)
Lung volume reduction surgery (1999) (8)
Gene therapy for asthma: inspired research or unnecessary effort? (1999) (8)
HIGH FREQUENCY OSCILLATIONS IMPROVE NASAL MUCOCILIARY TRANSPORT (1984) (8)
Identification of patients at high risk of chemotherapy-induced toxicity in small-cell lung cancer. (1988) (8)
Gene therapy for respiratory diseases: potential applications and difficulties. (1995) (7)
Extrinsic allergic bronchiolitis in a bird fancier. (1984) (7)
Prognostic factors in patients with small-cell lung cancer: preliminary results from a large randomised study. (1988) (7)
Lack of inhibition by dideoxy-forskolin and verapamil of DIDS-sensitive volume-activated Cl- secretion in human squamous lung carcinoma epithelial cells. (1994) (7)
Pseudomonas aeruginosa cross-infection in cystic fibrosis (2002) (7)
Gene therapy for cystic fibrosis: steady progress, should do well. (1997) (7)
Milking gene therapy (1998) (6)
Exertional haemoptysis: LAM and TSC (2003) (6)
A computer model of human respiration (1978) (6)
Effect of oral high frequency ventilation by jet or oscillator on minute ventilation in normal subjects. (1985) (6)
Taking stock of gene therapy for cystic fibrosis (2000) (6)
Segregation is not good for patients with cystic fibrosis (2008) (6)
Nedocromil sodium workshop. (1989) (6)
High frequency oscillations and mucociliary transport. (1989) (5)
Progress in research on cystic fibrosis. (1984) (5)
Effects of pulmonary circulation on blood levels of insulin and glucagon in ambulant dogs. (1979) (5)
Respiratory aspects of Shwachman's syndrome in adults. (1989) (5)
Asthma and enkephalin. (1980) (5)
Pseudomonas aeruginosa cross-infection in cystic fibrosis. Author's reply (2002) (5)
Age-specific effect of the cystic fibrosis modifier gene, MBL-2 (2002) (5)
Effects of 5-hydroxytryptamine and 5-hydroxytryptamine receptor agonists on ion transport across mammalian airway epithelia. (1992) (5)
Lower airway potential difference measurements in non-CF and CF subjects (1996) (4)
Cycling in patients with chronic airflow limitation. (1983) (4)
Gene therapy for cystic fibrosis. (1995) (4)
Cystic fibrosis: basic chemical and cellular mechanisms. (1996) (4)
Comprar Cystic Fibrosis | Margaret Hodson | 9780340907580 | Hodder Arnold (2007) (4)
Respiratory Fungal Infections and Allergic Bronchopulmonary Aspergillosis (2006) (4)
Tracheal potential difference in the reserpine and isoproterenol rat models of cystic fibrosis. (1990) (3)
356. Sonoporation Increases Non-Viral Gene Transfer to the Murine Lung (2005) (3)
The biochemical properties of the pulmonary circulation (2007) (3)
Dornase alfa for cystic fibrosis (1995) (3)
Systemic haemodynamic changes in patients with cystic fibrosis with and without chronic liver disease. (1996) (3)
Lack of effect of lung denervation on the measurement of potential difference after single-lung transplantation. (1989) (3)
The history of respiratory disease management (2016) (3)
473. Magnetofection to Enhance Airway Gene Transfer (2004) (3)
Prospects for respiratory gene therapy. (1997) (3)
An unusual cause of difficult asthma (2005) (2)
The Effect of Pulmonary Artery Occlusion and Shock Lung on Propranolol Uptake by the Lungs of Conscious Dogs (1980) (2)
Practical medicine : a guide to out-patient management (1976) (2)
Collateral ventilation and selection of techniques for bronchoscopic lung volume reduction (2012) (2)
Recent advances in cystic fibrosis. (1990) (2)
Thyroxine and dyspnoea in emphysema. (1981) (2)
Mismatched family and unrelated donors for bone marrow transplantation using fixed low numbers of t cells (1988) (2)
Cystic Fibrosis—from Lung Damage to Symptoms (1989) (2)
The history of respiratory disease management (2016) (2)
UKCF gene therapy consortium tracking study: Lung clearance index improves with treatment of an infective exacerbation (2007) (2)
The solitary pulmonary nodule. (1989) (2)
The Specificity of β-Adrenoceptors for the Release of Renin in Man (1975) (2)
Cystic fibrosis: towards the basic defect. (1988) (2)
Infection v. colonisation (2005) (2)
The future for a child born with cystic fibrosis today (2007) (2)
Bronchiolitis obliterans. A new form of rheumatoid lung? (1978) (2)
842. Repeated Administration of Sendai Virus into Lung (2005) (2)
Heart-lung transplantation for cystic fibrosis. (1992) (2)
Mood and peak flow in asthma (1992) (2)
Methotrexate: does it treat or induce asthma? (1992) (2)
Ornithosis pneumonia associated with haemolysis. (1977) (2)
Commentary: Retransplantation in a patient with cystic fibrosis (1998) (2)
Lung volume reduction surgery in pulmonary emphysema; results of a randomised, controlled trial (1999) (2)
Advising the traveller with lung disease. (1998) (2)
Tuberculosis skin tests (1996) (1)
Corticosteroid-resistant asthma: pathogenesis and clinical implications for management. (1998) (1)
Ototoxicity following once daily aminoglycoside administration in adults with CF (2008) (1)
Corticosteroids in asthma. (1990) (1)
Evaluation of the porcine ameroid constrictor model of chronic myocardial ischemia for therapeutic angiogenesis studies (2003) (1)
Unstable asthma and theophylline. (1991) (1)
The Kerley Pergamon Lecture: the role of the radiologist--a chest physician's view. (1992) (1)
Fibreoptic bronchoscopy in the intensive care unit (1980) (1)
Adult respiratory distress syndrome. Advances in diagnosis and ventilatory management. (1990) (1)
935. Magnetofection and Ultrasound To Increase “Naked” DNA Delivery to the Myocardium (2004) (1)
Management of residual thymic cysts in patients treated for mediastinal Hodgkin ' s disease (1)
Recombinant sendai virus mediates CFTR gene transfer to airway epithelium both in vitro and in vivo (2004) (1)
nebulisers . in cystic fibrosis : comparison of two Pulmonary deposition of nebulised amiloride (1)
Cystic fibrosis--from gene to therapy. (1991) (1)
Asthma and Pulmonary Eosinophilia (1981) (1)
Effect of IBMX and alkaline phosphatase inhibitors on Cl- secretion in G551D cystic fibrosis mutant mice. (1998) (1)
LAVAGE FOR INTESTINAL OBSTRUCTION IN CYSTIC FIBROSIS (1986) (1)
Radiotherapy in small cell cancer of the lung (1984) (1)
The Biochemical Function of the Pulmonary Circulation (1980) (1)
LacZ siRNA and antisense DNA decrease beta-galactosidase mRNA but not protein expression in the airways of K18-lacZ transgenic mice (2004) (1)
High frequency ventilation. (1985) (1)
Translational research--from gene to treatment: lessons from cystic fibrosis. (2005) (1)
Effect of β-Adrenoreceptor Blockade on Exercise Tolerance in Emphysema (1980) (1)
The prospects for gene therapy in cystic fibrosis. (1995) (1)
Erythromycin inhibits Cl secretion. (1992) (0)
Steroid dependent asthma: Authors' reply (1989) (0)
Practical Medicine (1976) (0)
Magnetofection to enhance transfection efficiency of large genomic context vectors in vitro (2004) (0)
xii + 256 Price £14.95 C.J. Dickinson, A Computer Model of Human Respiration , MTP Press, St Louis (1977). (1978) (0)
Reply to the letter from Dr Grant (1990) (0)
Results of clinical efficacy outcomes (2016) (0)
Dose preparation sheet (2016) (0)
Gene therapy Kenneth W Culver A primer for physicians (1996) (0)
The role of nebuliser therapy in cystic fibrosis. (1995) (0)
Images of the quarter: Talc granulomatous disease (2004) (0)
P139 Atelectasis following bronchoscopic lung volume reduction (BLVR) is associated with improved survival in COPD (2010) (0)
Perspectives in gene therapy (2001) (0)
Oxygen in the home (1981) (0)
Cystic Fibrosis Questionnaire – Revised quality-of-life questionnaire (2016) (0)
Patient information sheets (2016) (0)
Human alpha 1-antitrypsin gene transfer with cationic liposomes in vitro and in vivo (1996) (0)
Detailed functional and histologic characterisation of the murine myocardial infarction model (2002) (0)
The Kerley Pergamon Lecture: A Chest Physician's View (1992) (0)
Prognostic factors in patients with small cell lung cancer (SCLC) (1989) (0)
Mechanisms and Causes of Airflow Obstruction (1981) (0)
Sarcoidosis: when and how should we treat? (1995) (0)
Pp. 272. Price 45D. Geraint James and Peter R. Studdy, A Colour Atlas of Respiratory Diseases (1st edition), Wolfe Medical, London (1981). (1982) (0)
A Colour Atlas of Respiratory Diseases: D. Geraint James and Peter R. Studdy London: Wolfe Medical. 1981. 1st edition. Pp. 272. Price £45 (1982) (0)
Gene Therapy: The Case for Cystic Fibrosis (1997) (0)
Gene therapy. (1996) (0)
Inhaled budesonide for mild asthma. (1995) (0)
Thoracoscopy: assessment ofaphysician service and comparison ofaflexible bronchoscope usedasa thoracoscope wi-th arigid thoracoscope (1988) (0)
Comparison of the Effect of Propranolol with Atenolol and Metoprolol on the Dose—Response Curves of Catecholamine-Induced Changes in Ventilation (1980) (0)
Gene therapy for alpha 1-antitrypsin deficiency. (1995) (0)
Emphysema and Bullae (1981) (0)
Lidocaine increases lung uptake of propranolol (2007) (0)
Effect ofnitrazepam andflurazepam onthe ventilatory responsetocarbon dioxide (1976) (0)
Chapter 3.6. Lung Volume Reduction (2007) (0)
Import Determinants of Plasmid DNA Nuclear Characterization of Cytoplasmic Identification and Functional Developmental Biology : Molecular Basis of Cell and (2009) (0)
Optimisation of gene transfer to the murine myocardium (2003) (0)
The Release of Renin Provoked by Intravenous Isoprenaline in Man: A Dose—Response Relationship (1976) (0)
REVIEW ARTICLE Inhaled Corticosteroids: Benefits and Risks (1996) (0)
Tracheal structure abnormalities in Cftr − / − knockout mice (2007) (0)
507. Down-Regulation of the Epithelial Sodium Channel ENaC through Antisense Oligonucleotides (2004) (0)
Extrinsic allergic broncholitis in a bird fancier (0)
P u l m o n a ry disease severity in men with DF508 cystic fibrosis and residual chloride secre t i o n (1999) (0)
Radiosensitivity Testing of Normal Tissues: a Way to Optimise Radiotherapy? (1994) (0)
ERYTHROMYCIN INHIBITS CL SECRETION. AUTHOR'S REPLY (1992) (0)
Does Smoking have any Influence on the Course of Restrictive Lung Disease (1984) (0)
Case reports Commentary : “ Histiocytosis X ” (1998) (0)
Immunoglobulin and complement deposits in the lungs of New Zealand Black/White mice (1978) (0)
Peptide Hormones in Lung Cancer (Recent Results in Cancer Research, Vol. 99): Eds K. Havemann, G. Sorenson & C. Gropp Berlin: Springer-Verlag. 1985. 1st edition. Pp. 248. Price DM 138 (1987) (0)
Gene silencing through RNA interference and antisense strategies in the lung (2003) (0)
Steroid Sparing Therapies in Asthma (2000) (0)
699. Bactofection into Airway Epithelial Cells In Vitro and In Vivo Using a Genetically Modified Escherichia coli (2006) (0)
Optimisation of adenoviral and plasmid-mediated gene transfer to the murine myocardium (2004) (0)
The future: How will management change? (2015) (0)
Which patients should receive lung transplants? (1993) (0)
Assessment and Clinical Patterns (1981) (0)
In vitro and ex vivo approaches to determining the mechanisms of liposome-mediated gene transfer (1996) (0)
935. Magnetofection and Ultrasound To Increase |[ldquo]|Naked|[rdquo]| DNA Delivery to the Myocardium (2004) (0)
New developments in cystic fibrosis and their potential effects on its management (1993) (0)
Rare Causes of Airflow Obstruction (1981) (0)
Intensive chemotherapy and thoracic irradiation as induction treatment in small cell lung cancer (SCLC) (1989) (0)
720. Tolerisation of Mice To Allow Repeated Administration of Recombinant Sendai Virus Vector to the Airways (2004) (0)
Assessment of the Sensation of Breathlessness (1981) (0)
The management of lung cancer (1985) (0)
Commentary (1995) (0)
SURGERY FOR PULMONARY EMPHYSEMA (1983) (0)
REPRODUCIBILITY OF RELATIVE REGIONAL ASSESSMENT USING THE VIBRATION RESPONSE IMAGING DEVICE (2006) (0)
Book reviewLung Cancer: Joseph Aisner Edinburgh: Churchill Livingstone. 1985. 1st edition. Pp. 336. Price £40.00 (1986) (0)
Cystic fibrosis (2002) (0)
Lung Biology in Health and Disease, 10. Pathogenesis and Therapy of Lung Cancer, 10, Curtis C. Harris. Marcel Dekker, Oxford (1978), Pp. xx + 762. Price $59.50 (1979) (0)
Bronchiectasis and Cystic Fibrosis (1981) (0)
ConwayInstituteofBimolecularandBiomedicalResearch,UniversityCollegeDublin,Belfield,Dublin4,Ireland (2009) (0)
The Association of Clinical Pathologists: 99th spring Realistic in vitro tests of antibiotic activity (2004) (0)
Effect of Nitrazepam on Blood Gases and Ventilatory Response to co2 in Paltients with Chronic Bronchitis (1977) (0)
Abstract Treatment toxicity & long term sequelaeIdentification of patients at high risk of chemotherapy-induced toxicity in small cell lung cancer (SCLC) (1989) (0)
695. Low-Frequency Ultrasound Increases Non- Viral Lung Gene Transfer (2006) (0)
36 Feasibility of airway surface liquid (ASL) height measurement in human nasal and bronchial biopsies (2007) (0)
Intensive chemotherapy and thoracic irradiation as induction treatment in limited-stage small-cell lung cancer. (1988) (0)
Effects of alterations in intracellular and extracellular calcium on ion transport in guinea pig trachea in vitro (1988) (0)
Results of mechanistic substudy (2016) (0)
Methods: clinical trial design and outcome measures (2016) (0)
Perspectives in gene therapy (0)
Safety and adverse events (2016) (0)
Sex of children born to women with cystic fibrosis (1992) (0)
Pulmonary Eosinophilia (1986) (0)
Lung biology in health and disease, 10. Pathogenesis and therapy of lung cancer: Curtis C. Harris New York: Marcel Dekker. 1978. Pp. xx+762. Price $9.50 (1979) (0)
Bronchoscopic Techniques for Treating Emphysema (2006) (0)
Gene Therapy for Lung Diseases (2006) (0)
GENE THERAPY FOR RESPIRATORY DISEASE (1998) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Dr. Duncan M. Geddes?

Dr. Duncan M. Geddes is affiliated with the following schools: